A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.
Status:
Completed
Trial end date:
2020-02-21
Target enrollment:
Participant gender:
Summary
Objective of this study is to investigate the efficacy, safety and pharmacokinetics of
KDT-3594 in patients with early Parkinson's disease without a concomitant medication of
L-dopa.